Cash & equivalents increased 24.7%
Cash & equivalents changed +24.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +24.7% from the comparable as-filed period.
Gross margin changed +162 basis points from the comparable as-filed period.
Gross profit changed +48.4% from the comparable as-filed period.
Net income changed +66.7% from the comparable as-filed period.
Operating income changed +109.0% from the comparable as-filed period.
Revenue changed +28.3% from the comparable as-filed period.
Stock-based compensation changed +20.0% from the comparable as-filed period.
Research & development changed +15.5% from the comparable as-filed period.
Operating margin changed +115 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.